Review
Open access
Sep 2026
Triazole‐ and Imidazole‐Containing Compounds: Versatile VEGFR‐2 Inhibitors for Cancer Therapy
This review compiles in vitro, in vivo, and in silico data on triazole‐ and imidazole‐based VEGFR‐2 inhibitors, providing a basis for understanding trends relevant to the design and development of optimized anti‐angiogenic agents.
Parisa Nikfar, Mina Hosseini, Nima Rezaei et al.
· Archiv der Pharmazie · 0 citations